Search clinical trials for: recombinant follicle stimulating hormone (FSH)

Total 856 results

Instituto Bernabeu

Unknown

Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial) (GENODON)

Reproductive Techniques, Assisted

Spain
IVI Madrid

Terminated

Aneuploidy Rate and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH

Aneuploidy Rate

Spain
IVI Madrid

Terminated

Embryo Kinetics and Stimulation Protocol: Recombinant Follicle Stimulating Hormone (FSH) Versus Human FSH

Embryo Kinetics

Spain
Universitair Ziekenhuis Brussel

Completed

Initiation of Ovarian Stimulation With Recombinant-human FSH (Bemfola®) in the Late Follicular Phase

Infertility, Female

Belgium
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles

Ovarian Stimulation

Spain
National and Kapodistrian University of Athens

Completed

Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation

Infertility

Greece
Merck KGaA, Darmstadt, Germany

Terminated

Low-dose Gonal-f® in Ovulation Induction (LoGo)

Infertility | Monofollicular Development

United Kingdom, Ireland
Merck KGaA, Darmstadt, Germany
Merck N.V.-S.A., Belgium

Terminated

An Observational Study to Compare the Dose of Gonal-fTM FbM Prescribed by the Doctor With the Recommendation of the Dose Calculator Consort and to Evaluate the Ease of Use of Pre-filled Pen of Gonal-fTM FbM Pen

Multifollicular Stimulation

Belgium
Glycotope GmbH
Glycotope Biotechnology GmbH

Completed

Multiple Dose FSH-GEX(TM) in Healthy Volunteers

Female Infertility

Netherlands
Royan Institute

Unknown

Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism

Infertility

Iran, Islamic Republic of
IBSA Institut Biochimique SA

Completed

Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation Cycles

Oocyte Donation

Spain
Merck KGaA, Darmstadt, Germany
Merck, S.L., Spain

Terminated

A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive Age

Infertility | Ovulation Induction

Spain
Merck KGaA, Darmstadt, Germany
Merck Serono S.P.A., Italy

Terminated

Study to Evaluate if the Addition of r-hLH (Luveris®) to FSH From Day 8 of Ovarian Stimulation is Able to Decrease Total FSH Dose and to Improve Cycle Outcome in Infertile Women Undergoing ART, Who Required High FSH Dose in a Previous Cycle (Luveris in ART)

Reproductive Techniques, Assisted

Italy
Merck KGaA, Darmstadt, Germany

Completed

GONAL-f CONSORT (Consistency in r-hFSH Starting Doses for Individualised Treatment)

Infertility

Germany
Merck KGaA, Darmstadt, Germany

Completed

A Study to Evaluate the Ease of Use, Local Tolerance, Safety and Effectiveness of Gonal-f® (Filled-by-mass in a Prefilled Pen)

Infertility

Greece
National Foundation for Fertility Research
Fertility Laboratories Of Colorado

Unknown

In Vitro Maturation of Human Eggs (IVM)

Infertility | Reproductive Techniques, Assisted

United States
University of California, San Diego
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS

Healthy | Polycystic Ovary Syndrome | Hyperandrogenism | Anovulation

United States
Merck KGaA, Darmstadt, Germany

Completed

CONSORT Randomized Controlled Trial in Assisted Reproductive Technology

Infertility

Switzerland
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles

Ovarian Stimulation

Spain
Merck KGaA, Darmstadt, Germany

Completed

A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve

Infertility | Ovulation Induction

Spain
Merck KGaA, Darmstadt, Germany

Completed

Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF) (CONSORT)

Infertility

France
IRCCS Azienda Ospedaliera Universitaria San Martino...

Completed

Second Laparoscopic Surgery for Recurrent Unilateral Endometriomas.

Endometriosis | Surgery | Endometrioma

Italy
Merck KGaA, Darmstadt, Germany
Merck Pte. Ltd., Singapore

Completed

A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism

Hypogonadism

China
Merck KGaA, Darmstadt, Germany
Merck Serono Middle East FZ-LLC, United Arab Emirates, an affiliate of Merck...

Completed

Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction

Ovulation Induction

Kuwait, Lebanon, Saudi Arabia
Rigshospitalet, Denmark
Odense University Hospital; Karolinska University Hospital; Hvidovre University... and other collaborators

Completed

Nordic Luveris Study

Infertility | In Vitro Fertilization

Denmark
Eunice Kennedy Shriver National Institute of Child...

Terminated

Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism

Kallmann Syndrome | Hypogonadism

United States
Main Line Fertility Center

Completed

Mono-menotropins Versus rFSH Protocol on Embryo Quality

Infertility | Fertility

United States
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., Japan

Completed

SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women

Infertility | Ovulation Induction

Japan
Ferring Pharmaceuticals

Completed

A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa

Infertility

Germany, United Kingdom
IBSA Institut Biochimique SA

Completed

FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST) (FAST)

Infertility

Italy, Belgium, Turkey, Spain, Switzerland, United Kingdom
Vietnam National University

Completed

Efficacy of Pergoveris in Aged IVF Patients

Infertility

Vietnam
Merck KGaA, Darmstadt, Germany
Merck Serono S.A.S, France

Completed

Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART) (ATTAC-PCO)

Polycystic Ovarian Syndrome

France
Assiut University

Unknown

Sexual Maturation in β-Thalassemia Major Patients in Assiut University Hospital

β-Thalassemia Major Patients Receiving Chelation Therapy
EMD Serono

Terminated

Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])

Hypogonadotropic Hypogonadism

United States
IBSA Institut Biochimique SA

Completed

Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.

Infertility

France, Hungary
Merck KGaA, Darmstadt, Germany

Completed

A Prospective, Multi-centric Observational Study to Determine the Mono-bifollicular Development in Infertile Women Subjected to Ovulation Induction With Follitropin α (P450)

Ovulation Induction

Spain
Merck KGaA, Darmstadt, Germany

Completed

Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel

Embryo Transfer | Luteal Hormone Supplementation in In-vitro Fertilization

Japan
Bloom IVF and Fertility Centre
Padmashree Dr. D. Y. Patil Medical College

Unknown

Assessment of Implantation Potential of Embryos by Time-lapse Technology (Embryoscope)

Aneuploidy | Blastocyst Disintegration | Embryo/Fetus Death | Complication of Implant | Chemical Pregnancy

India
Glycotope GmbH
Glycotope Biotechnology GmbH

Completed

Single Dose FSH-GEX™ in Healthy Volunteers

Female Infertility

Netherlands
Merck KGaA, Darmstadt, Germany

Completed

Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)

Infertility

United States
Merck KGaA, Darmstadt, Germany

Terminated

AS900672-Enriched in Ovulation Induction

Ovulation Induction

Switzerland
Bezmialem Vakif University

Recruiting

Comparison of Recombinant Follicle Stimulating Hormone and the Combination of Recombinant Follicle Stimulating Hormone With Clomiphene Citrate in Stimulated Intrauterine Insemination Cycles

Infertility Unexplained

Turkey
Shandong University
The Second Hospital of Hebei Medical University; Sun Yat-Sen Memorial Hospital... and other collaborators

Unknown

Age-related Variability of the Efficacy and Tolerability of Alternative Pituitary Suppression Regimens in ART

Infertility

China
Peking University People's Hospital
Peking University First Hospital; The Second Hospital of Hebei Medical University and other collaborators

Unknown

The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation

Infertility, Female
IVI Madrid

Completed

Higher Dose of Rekovelle in Oocyte Donors (REKO15)

IVF

Spain
Merck KGaA, Darmstadt, Germany
Merck Serono Co., Ltd., China

Completed

A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation (ARTIST)

Polycystic Ovary Syndrome

Germany
Bharat Serums and Vaccines Limited

Active, not recruiting

Recombinant Follicle-stimulating Hormone in Treatment for Infertility (REFRESH)

Female Infertility

India
Organon and Co

Completed

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713) (Care)

Pregnancy | Neonates
ART Fertility Clinics LLC
Merck Serono International SA

Completed

Step Down FSH Approach and Late Follicular Phase in Progesterone Level (FSH)

Progesterone Resistance

United Arab Emirates
H. Lee Moffitt Cancer Center and Research Institute
Anixa Biosciences, Inc.

Recruiting

Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer

Ovarian Cancer

United States

3

Subscribe